148 related articles for article (PubMed ID: 36909572)
21. Silk fibroin carriers with sustained release capacity for treating neurological diseases.
Huang X; An Y; Yuan S; Chen C; Shan H; Zhang M
Front Pharmacol; 2023; 14():1117542. PubMed ID: 37214477
[TBL] [Abstract][Full Text] [Related]
22. Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: confirmation by size-exclusion HPLC.
Varlet-Marie E; Ashenden M; Lasne F; Sicart MT; Marion B; de Ceaurriz J; Audran M
Clin Chem; 2004 Apr; 50(4):723-31. PubMed ID: 14764640
[TBL] [Abstract][Full Text] [Related]
23. Formulation of Biologically-Inspired Silk-Based Drug Carriers for Pulmonary Delivery Targeted for Lung Cancer.
Kim SY; Naskar D; Kundu SC; Bishop DP; Doble PA; Boddy AV; Chan HK; Wall IB; Chrzanowski W
Sci Rep; 2015 Aug; 5():11878. PubMed ID: 26234773
[TBL] [Abstract][Full Text] [Related]
24. Manual Versus Microfluidic-Assisted Nanoparticle Manufacture: Impact of Silk Fibroin Stock on Nanoparticle Characteristics.
Solomun JI; Totten JD; Wongpinyochit T; Florence AJ; Seib FP
ACS Biomater Sci Eng; 2020 May; 6(5):2796-2804. PubMed ID: 32582839
[TBL] [Abstract][Full Text] [Related]
25. Blood Component Requirements and Erythrocyte Transfusion and Mortality Related to Hemoglobin Deficit in Phase III Trial of Hemoglobin-Based Oxygen Carrier: HBOC-201.
Jahr JS; Williams JP
Am J Ther; 2022 May-Jun 01; 29(3):e279-e286. PubMed ID: 35421008
[TBL] [Abstract][Full Text] [Related]
26. Role of redox potential of hemoglobin-based oxygen carriers on methemoglobin reduction by plasma components.
Dorman SC; Kenny CF; Miller L; Hirsch RE; Harrington JP
Artif Cells Blood Substit Immobil Biotechnol; 2002 Jan; 30(1):39-51. PubMed ID: 12000225
[TBL] [Abstract][Full Text] [Related]
27. Progress in Preparation of Silk Fibroin Microspheres for Biomedical Applications.
Long S; Xiao Y; Zhang X
Pharm Nanotechnol; 2020; 8(5):358-371. PubMed ID: 33038918
[TBL] [Abstract][Full Text] [Related]
28. In Vitro MCF-7 Cells Apoptosis Analysis of Carboplatin Loaded Silk Fibroin Particles.
Galam N; Tulay P; Adali T
Molecules; 2020 Mar; 25(5):. PubMed ID: 32131498
[TBL] [Abstract][Full Text] [Related]
29. Effect of aqueous and particulate silk fibroin in a rat model of experimental colitis.
Rodriguez-Nogales A; Lozano-Pérez AA; Aznar-Cervantes SD; Algieri F; Garrido-Mesa J; Garrido-Mesa N; Vezza T; Utrilla MP; Cenis JL; Rodríguez-Cabezas ME; Gálvez J
Int J Pharm; 2016 Sep; 511(1):1-9. PubMed ID: 27363935
[TBL] [Abstract][Full Text] [Related]
30. Review of hemoglobin-vesicles as artificial oxygen carriers.
Sakai H; Sou K; Horinouchi H; Kobayashi K; Tsuchida E
Artif Organs; 2009 Feb; 33(2):139-45. PubMed ID: 19178458
[TBL] [Abstract][Full Text] [Related]
31. Optimization of Hemoglobin Encapsulation within PLGA Nanoparticles and Their Investigation as Potential Oxygen Carriers.
Coll-Satue C; Jansman MMT; Thulstrup PW; Hosta-Rigau L
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834373
[TBL] [Abstract][Full Text] [Related]
32. Selective Encapsulation of the Polyphenols on Silk Fibroin Nanoparticles: Optimization Approaches.
Bayraktar O; Oder G; Erdem C; Kose MD; Cheaburu-Yilmaz CN
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298277
[TBL] [Abstract][Full Text] [Related]
33. Dual-Mode Cross-Linking Enhances Adhesion of Silk Fibroin Hydrogels to Intestinal Tissue.
Heichel DL; Burke KA
ACS Biomater Sci Eng; 2019 Jul; 5(7):3246-3259. PubMed ID: 33405568
[TBL] [Abstract][Full Text] [Related]
34. The Emerging Role of Silk Fibroin for the Development of Novel Drug Delivery Systems.
Pollini M; Paladini F
Biomimetics (Basel); 2024 May; 9(5):. PubMed ID: 38786505
[TBL] [Abstract][Full Text] [Related]
35. Magnetic-Silk Core-Shell Nanoparticles as Potential Carriers for Targeted Delivery of Curcumin into Human Breast Cancer Cells.
Song W; Muthana M; Mukherjee J; Falconer RJ; Biggs CA; Zhao X
ACS Biomater Sci Eng; 2017 Jun; 3(6):1027-1038. PubMed ID: 33429579
[TBL] [Abstract][Full Text] [Related]
36. Resuscitation with a hemoglobin-based oxygen carrier after traumatic brain injury.
King DR; Cohn SM; Proctor KG
J Trauma; 2005 Sep; 59(3):553-60; discussion 560-2. PubMed ID: 16361895
[TBL] [Abstract][Full Text] [Related]
37. In silico-in vitro-in vivo studies of experimentally designed carvedilol loaded silk fibroin-casein nanoparticles using physiological based pharmacokinetic model.
Kumar S; Singh SK
Int J Biol Macromol; 2017 Mar; 96():403-420. PubMed ID: 28013012
[TBL] [Abstract][Full Text] [Related]
38. [The preparation and properties of Modified silk fibroin membranes by chitosan].
Liu L; Wu Z; Li P; Cai S; Chen X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Aug; 21(4):587-90. PubMed ID: 15357438
[TBL] [Abstract][Full Text] [Related]
39. Pharmaceutical aspects of hemoglobin-based oxygen carriers.
Awasthi V
Curr Drug Deliv; 2005 Apr; 2(2):133-42. PubMed ID: 16305414
[TBL] [Abstract][Full Text] [Related]
40. Recognition mechanisms of hemoglobin particles by monocytes - CD163 may just be one.
Nimz JG; Rerkshanandana P; Kloypan C; Kalus U; Chaiwaree S; Pruß A; Georgieva R; Xiong Y; Bäumler H
Beilstein J Nanotechnol; 2023; 14():1028-1040. PubMed ID: 37915310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
